Results for tag: "Sonidegib"

Sonidegib is a drug used to treat a type of lung cancer known as non-small cell lung cancer (NSCLC). It is a hedgehog pathway inhibitor, meaning it works by blocking the hedgehog pathway, which is a signaling pathway involved in the growth and spread of cancer cells. Sonidegib is used in combination with other drugs to treat NSCLC, and is typically prescribed to patients who have already undergone chemotherapy or radiation therapy. Sonidegib is a relatively new drug, having been approved by the US Food and Drug Administration (FDA) in 2018. It is currently the only hedgehog pathway inhibitor approved for the treatment of NSCLC. The Sonidegib market is a rapidly growing one, as the drug is increasingly being used to treat NSCLC. It is expected to continue to grow in the coming years, as more patients are prescribed the drug and as new treatments are developed. Some companies in the Sonidegib market include Novartis, Pfizer, and Gilead Sciences. Show Less Read more